Ad is loading...
DNFGX
Price
$45.75
Change
-$1.15 (-2.45%)
Updated
Nov 15 closing price
RGACX
Price
$77.24
Change
-$1.30 (-1.66%)
Updated
Nov 15 closing price
Ad is loading...

DNFGX vs RGACX

Header iconDNFGX vs RGACX Comparison
Open Charts DNFGX vs RGACXBanner chart's image
Dunham Focused Large Cap Growth N
Price$45.75
Change-$1.15 (-2.45%)
VolumeN/A
CapitalizationN/A
American Funds Growth Fund of Amer R3
Price$77.24
Change-$1.30 (-1.66%)
VolumeN/A
CapitalizationN/A
DNFGX vs RGACX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DNFGX vs. RGACX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DNFGX is a StrongBuy and RGACX is a StrongBuy.

FUNDAMENTALS
Fundamentals
RGACX has more cash in the bank: 298B vs. DNFGX (190M). RGACX pays higher dividends than DNFGX: RGACX (0.25) vs DNFGX (0.00). DNFGX was incepted earlier than RGACX: DNFGX (13 years) vs RGACX (23 years). RGACX is a more actively managed with annual turnover of: 31.00 vs. DNFGX (17.00). RGACX has a lower initial minimum investment than DNFGX: RGACX (250) vs DNFGX (100000). DNFGX annual gain was more profitable for investors over the last year : 32.85 vs. RGACX (27.34). DNFGX return over 5 years is better than : 81.56 vs. RGACX (51.21).
DNFGXRGACXDNFGX / RGACX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years23 years-
Gain YTD25.59226.12798%
Front LoadN/AN/A-
Min. Initial Investment10000025040,000%
Min. Initial Investment IRAN/AN/A-
Net Assets190M298B0%
Annual Yield % from dividends0.000.25-
Returns for 1 year32.8527.34120%
Returns for 3 years-0.04-5.451%
Returns for 5 years81.5651.21159%
Returns for 10 years205.8466.99307%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BBDC9.950.06
+0.61%
Barings BDC
TU15.17-0.01
-0.07%
Telus Corp
BDC118.61-1.20
-1.00%
Belden
COCP2.15-0.05
-2.27%
Cocrystal Pharma
FATE2.02-0.06
-2.88%
Fate Therapeutics